Nwam LLC Acquires 5,575 Shares of Danaher Corporation $DHR

Nwam LLC grew its holdings in shares of Danaher Corporation (NYSE:DHR) by 55.2% during the 1st quarter, Holdings Channel reports. The institutional investor owned 15,675 shares of the conglomerate’s stock after acquiring an additional 5,575 shares during the quarter. Nwam LLC’s holdings in Danaher were worth $2,972,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. JPL Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC bought a new stake in Danaher in the second quarter worth $26,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the fourth quarter worth $26,000. Hilton Head Capital Partners LLC purchased a new position in Danaher during the fourth quarter worth $27,000. Finally, Clal Insurance Enterprises Holdings Ltd increased its position in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. HSBC reduced their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Weiss Ratings downgraded shares of Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, June 29th. The Goldman Sachs Group reduced their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Wells Fargo & Company decreased their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. Finally, Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $231.64.

Danaher Trading Down 0.5%

NYSE DHR opened at $199.06 on Wednesday. The stock has a market cap of $140.89 billion, a PE ratio of 38.50, a PEG ratio of 2.55 and a beta of 0.79. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company’s 50-day moving average price is $181.51 and its 200-day moving average price is $198.83. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the business posted $1.88 EPS. Equities research analysts forecast that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.